U.S. Software Stock News

In early May 2026, Vertex Pharmaceuticals reported past first-quarter 2026 results showing revenue of US$2,986.9 million and net income of US$1,031.4 million, alongside reaffirmed full-year revenue guidance of US$12.95 billion to US$13.10 billion. The quarter also underscored Vertex’s push beyond cystic fibrosis, with expanding access to CASGEVY gene therapy and progress in its emerging renal franchise, including regulatory momentum for povitacicept in IgA nephropathy. We’ll now examine how...

If you are wondering whether Eli Lilly's near US$1,000 share price still offers value, you are not alone. The numbers give you plenty to think about. The stock recently closed at US$987.05, with returns of 16.0% over 7 days, 6.5% over 30 days, a year to date return of an 8.6% decline, and 28.0% over 1 year, plus a very large 3 year gain and a roughly 4x return over 5 years. Recent headlines have focused heavily on Eli Lilly's pipeline and high profile therapies, which have kept the stock...

Recent Share Performance and Business Mix International Business Machines (IBM) has drawn investor attention after a recent pullback, with the stock showing negative returns over the past month and past 3 months and sitting below its year to date level. At a last close of US$225.74 and a market value of about US$215.3b, the company combines sizeable revenue from software, consulting, infrastructure and financing. This provides several business drivers to watch within a single stock. See our...

Recent interest in Eos Energy Enterprises (EOSE) has been shaped by expectations for an upcoming earnings per share surprise and the appointment of experienced finance leader Alessandro Lagi as Chief Financial Officer. See our latest analysis for Eos Energy Enterprises. The recent excitement around earnings expectations and the CFO appointment comes after a mixed price pattern, with a 46.9% 90 day share price decline contrasting with a 46.0% 30 day share price return and a very large 3 year...

Q1 2026 earnings snapshot TransMedics Group (TMDX) has just posted Q1 2026 results with revenue of US$173.9 million, basic EPS of US$0.21 and net income of US$7.3 million, set against a current share price of US$72.92. The company has reported revenue of US$121.6 million in Q4 2024 and US$173.9 million in Q1 2026, while quarterly basic EPS moved from US$0.20 to US$0.21 over the same span. With trailing earnings growth and a higher net profit margin in the background, this quarter’s numbers...

TIC Solutions, Inc. reported first-quarter 2026 results, with sales rising to US$488.03 million from US$234.22 million a year earlier, while net loss widened to US$41.55 million. The quarter highlighted the impact of the NV5 Global acquisition, as record revenue and reaffirmed 2026 guidance contrasted with continued losses and higher financing costs. We’ll now examine how the record NV5-driven revenue and reaffirmed 2026 outlook reshape TIC Solutions’ longer-term investment narrative. The...

Pulse Biosciences recently reported first-quarter 2026 results showing a wider net loss of US$18.58 million and basic loss per share of US$0.27, while also missing consensus revenue expectations with about US$0.4 million in sales. At the same time, the company released late-breaking, positive first-in-human data for its nPulse Cardiac Catheter System in atrial fibrillation, reinforcing confidence in its non-thermal nsPFA platform with high procedural success, durable rhythm control and a low...

CVS Health (CVS) opened 2026 with Q1 revenue of about US$100.4 billion and basic EPS of US$2.31, setting the tone for this reporting season. The company has seen quarterly revenue move from US$94.1 billion in Q1 2025 to US$100.4 billion in Q1 2026, while basic EPS over the same quarters shifted from US$1.41 to US$2.31, and trailing twelve month EPS now sits at roughly US$2.31 on revenue of US$405.7 billion. With reported net margins over the last year sitting at 0.7% and influenced by a large...

If you are wondering whether Levi Strauss stock still offers value after its recent run, or if you may be late to the party, this article breaks down what the current price might be implying about the company. With the share price at US$23.03 and returns of 5.2% over 7 days, 17.2% over 30 days, 10.6% year to date and 42.8% over 1 year, many investors are questioning what is already priced in. Those moves sit alongside a longer record, with returns of 83.4% over 3 years but a 4.9% decline...

Nexa Resources has already reported a strong first quarter of 2026, with net revenues rising to about US$888 million and net income reaching US$118 million on the back of higher metal prices, stronger smelting volumes, and resolved disruptions in Peru. A key shift was the Cerro Lindo silver streaming step-down, which cut the streamed share from 65% to 25% after a delivery threshold, allowing Nexa to retain and sell an additional 1.2–1.3 million ounces of silver at spot prices from the second...

AMC Entertainment Holdings (AMC) opened Q1 2026 with revenue of US$1,045.4 million and a basic EPS loss of US$0.22, compared with Q1 2025 revenue of US$862.5 million and a basic EPS loss of US$0.47 as the stock trades around US$1.64. Over the past year, revenue has ranged between US$862.5 million and US$1,397.9 million per quarter, while quarterly basic EPS losses have moved between roughly US$0.01 and US$0.58, leaving investors focused on how much of that top line is dropping through to the...

Kosmos Energy (NYSE:KOS) reports record production in Q1 2026, linked to the GTA and Jubilee field expansions. The company announces a US$350 million bond issue and a US$200 million equity raise, with proceeds aimed at reducing debt. Kosmos agrees to sell its Equatorial Guinea assets for up to US$220 million, while also taking final investment decision on the Tiberius project. These operational and financing actions come alongside ongoing losses and amount to a broad portfolio and balance...

Why Septerna stock is on investors’ radar Septerna (SEPN) stock has drawn attention after recent trading, with the share price closing at US$24.71 and short term returns showing mixed moves over the past week and month. See our latest analysis for Septerna. That recent uptick in Septerna’s share price, with a 1 day share price return of 2.40% and 7 day share price return of 4.00%, sits against a weaker year to date share price return of an 11.69% decline, even as the 1 year total shareholder...

Blue Bird Corporation recently reported past second-quarter 2026 results showing sales of US$352.64 million and net income of US$29.3 million, alongside filing a US$57.05 million shelf registration for 900,000 common shares tied to an ESOP offering. Despite slightly lower quarterly sales than a year earlier, Blue Bird increased earnings per share, highlighting efficiency gains just as its electric buses, such as those adopted by Bibb County School District, continue to gain traction. Next,...

Eli Lilly (NYSE:LLY) is committing $4.5b to expand its Indiana manufacturing footprint. The investment includes the Lebanon Advanced Therapies facility, the company’s first dedicated genetic medicine manufacturing site. The expansion also increases capacity for weight management and cardiometabolic drugs such as Foundayo and retatrutide. Eli Lilly is involved in two major themes investors are watching closely: obesity treatments and cardiometabolic care. The new Indiana facilities extend...

Harmony Biosciences Holdings, Inc. reported its Q1 2026 results before the market opened on May 7, 2026, followed by an earnings call the same day. The quarter drew attention because analysts had recently raised earnings estimates and highlighted Harmony’s projected earnings per share growth and cash-flow strength. Now, we’ll examine how these upward earnings estimate revisions and analyst optimism may influence Harmony Biosciences’ existing investment narrative. Invest in the nuclear...

In early May 2026, Newell Brands reported first-quarter results showing sales of US$1,549 million versus US$1,566 million a year earlier, with net loss narrowing to US$33 million and loss per share improving to US$0.08 from US$0.09. At the same time, the company lifted its full-year 2026 net sales outlook to a range of flat to 2% growth, suggesting management sees recent operational improvements as sustainable despite only modest recent sales movement. Now, we'll examine how Newell’s...

Wondering if Diamondback Energy's share price still offers value after a strong run, or if most of the opportunity is already priced in. The stock closed at US$195.08, with a 7 day return of a 5.1% decline, a 30 day return of a 0.2% decline, a 28.1% return year to date, and a 47.2% return over the last year. These figures can affect how you think about both upside potential and risk today. Recent news around US shale producers has kept attention on oil supply discipline and capital returns...

Tigo Energy (TYGO) opened Q1 2026 with revenue of US$25.2 million and a basic EPS loss of US$0.02, alongside net income of US$1.8 million in losses. The trailing twelve month line shows revenue of US$109.9 million and basic EPS of US$0.05 supported by net income of US$3.4 million. The company has seen quarterly revenue move from US$18.8 million in Q1 2025 to US$25.2 million in Q1 2026, with basic EPS shifting from a loss of US$0.11 to a loss of US$0.02. This positions a story where improving...

Huntington Ingalls Industries (NYSE:HII) has received a $283 million lead yard support contract for the U.S. Navy's FF(X) class frigate program. The company also secured a Defense Innovation Unit award to develop an autonomous launch and recovery system for submarine deployed unmanned underwater vehicles. These contracts expand HII's work in advanced surface warships and undersea autonomy for future naval operations. For investors tracking defense exposure, NYSE:HII sits at the intersection...

Volkswagen has significantly increased its stake and shared voting power in Rivian Automotive (NasdaqGS:RIVN), signaling a deeper tie-up between the two companies. Rivian has secured additional private funding from SMB Holding and Uber, adding to its capital base and expanding existing partnerships. The company is accelerating product and technology development, including in-house lidar and chip programs, undisclosed R2 variants, and ongoing plant expansion that affects its capital...

Madrigal Pharmaceuticals (MDGL) opened Q1 2026 with total revenue of US$311.3 million, a basic EPS loss of US$4.13, and net income loss of US$94.4 million, setting the tone for how its growth story is feeding through to the income statement. The company has seen reported quarterly revenue move from US$137.3 million in Q1 2025 to US$311.3 million in Q1 2026. Over the same period, basic EPS ranged from a loss of US$1.90 in Q2 2025 to a loss of US$5.08 in Q3 2025, so investors are watching how...

In late April 2026, Parker-Hannifin reported third-quarter fiscal 2026 results showing higher sales of US$5,486 million but slightly lower net income of US$904 million year over year, raised full-year guidance to about US$27.10 in diluted EPS on 7% reported sales growth, increased its quarterly dividend to US$2.00 per share, and continued share repurchases under its long-running buyback program. This mix of stronger top-line growth, ongoing capital returns, and only modest profit compression...

If you are wondering whether Corning at US$181.57 is still offering value after a big run, or if you are late to the story, this article walks through what the current price might be implying. The stock has logged returns of 19.5% over 7 days, 23.9% over 30 days, 100.3% year to date and 310.9% over the last year, with a very large 3 year return and 384.1% over 5 years, which naturally raises questions about how much potential future upside or downside is already priced in. Recent coverage...